142 related articles for article (PubMed ID: 36800492)
1. Impact of Topical Cyclosporine-A or Topical Chloroquine on Post-LASIK Ocular Surface Stability - A Randomized Controlled Trial.
Titiyal JS; Goswami A; Kaur M; Sharma N; Maharana PK; Velpandian T; Pandey RM
Curr Eye Res; 2023 Jun; 48(6):557-563. PubMed ID: 36800492
[TBL] [Abstract][Full Text] [Related]
2. Topical cyclosporine A therapy for dry eye syndrome.
de Paiva CS; Pflugfelder SC; Ng SM; Akpek EK
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010051. PubMed ID: 31517988
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Topical Chloroquine in Mild to Moderate Dry Eye Disease.
Titiyal JS; Kaur M; Falera R; Bharghava A; Sah R; Sen S
Curr Eye Res; 2019 Dec; 44(12):1306-1312. PubMed ID: 31283891
[No Abstract] [Full Text] [Related]
4. Impact of Topical 0.05% Cyclosporine A Eye Drops on Post-Femtosecond-Assisted Laser In Situ Keratomileusis Ocular Surface Recovery: A Randomized Clinical Trial.
Zhao L; Duan H; Ma B; Yang T; Zhou Y; Liu Y; Chen J; Chen Y; Qi H
Eye Contact Lens; 2024 Jun; ():. PubMed ID: 38865592
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
6. Topical cyclosporine A for postoperative photorefractive keratectomy and laser in situ keratomileusis.
Hessert D; Tanzer D; Brunstetter T; Kaupp S; Murdoch D; Mirzaoff M
J Cataract Refract Surg; 2013 Apr; 39(4):539-47. PubMed ID: 23415779
[TBL] [Abstract][Full Text] [Related]
7. Oral vitamin D
Lin Y; Su H; Wu J; Yuan M; Zhang Y
Int Ophthalmol; 2022 Oct; 42(10):3145-3152. PubMed ID: 35551580
[TBL] [Abstract][Full Text] [Related]
8. Dry eye disease after refractive surgery: comparative outcomes of small incision lenticule extraction versus LASIK.
Denoyer A; Landman E; Trinh L; Faure JF; Auclin F; Baudouin C
Ophthalmology; 2015 Apr; 122(4):669-76. PubMed ID: 25458707
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of point-of-care test for elevated tear matrix metalloproteinase 9 in post-LASIK dry eyes.
Chan TC; Ye C; Chan KP; Chu KO; Jhanji V
Br J Ophthalmol; 2016 Sep; 100(9):1188-91. PubMed ID: 26682569
[TBL] [Abstract][Full Text] [Related]
10. Dry Eye after Small Incision Lenticule Extraction (SMILE) versus Femtosecond Laser-Assisted in Situ Keratomileusis (FS-LASIK) for Myopia: A Meta-Analysis.
Shen Z; Zhu Y; Song X; Yan J; Yao K
PLoS One; 2016; 11(12):e0168081. PubMed ID: 27992482
[TBL] [Abstract][Full Text] [Related]
11. Thin-Flap Laser In Situ Keratomileusis-Associated Dry Eye: A Comparative Study Between Femtosecond Laser and Mechanical Microkeratome-Assisted Laser In Situ Keratomileusis.
Abdel-Radi M; Abdelmotaal H; Anwar M
Eye Contact Lens; 2022 Jan; 48(1):20-26. PubMed ID: 34644283
[TBL] [Abstract][Full Text] [Related]
12. Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery.
Shetty R; Khamar P; Nair AP; Pandian PR; Vaidya TA; Trivedi D; Sethu S; Roy S; Mahajan S; Shirodkar S
Indian J Ophthalmol; 2023 Apr; 71(4):1508-1516. PubMed ID: 37026292
[TBL] [Abstract][Full Text] [Related]
13. Effect of laser in situ keratomileusis on tear stability.
Yu EY; Leung A; Rao S; Lam DS
Ophthalmology; 2000 Dec; 107(12):2131-5. PubMed ID: 11097583
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor concentration and implications in photorefractive keratectomy vs laser in situ keratomileusis.
Lee HK; Lee KS; Kim HC; Lee SH; Kim EK
Am J Ophthalmol; 2005 Jun; 139(6):965-71. PubMed ID: 15953424
[TBL] [Abstract][Full Text] [Related]
15. Topical corticosteroids for dry eye.
Liu SH; Saldanha IJ; Abraham AG; Rittiphairoj T; Hauswirth S; Gregory D; Ifantides C; Li T
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD015070. PubMed ID: 36269562
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the effect of cyclosporine-A 0.05% emulsion on the ocular surface and corneal sensation following cataract surgery.
Hamada S; Moore TC; Moore JE; Al-Dreihi MG; Anbari A; Shah S
Cont Lens Anterior Eye; 2016 Feb; 39(1):15-9. PubMed ID: 26275686
[TBL] [Abstract][Full Text] [Related]
17. Effects of laser in situ keratomileusis on tear production, clearance, and the ocular surface.
Battat L; Macri A; Dursun D; Pflugfelder SC
Ophthalmology; 2001 Jul; 108(7):1230-5. PubMed ID: 11425680
[TBL] [Abstract][Full Text] [Related]
18. Prospective Randomized Trial Comparing Efficacy of Topical Loteprednol Etabonate 0.5% Versus Cyclosporine-A 0.05% for Treatment of Dry Eye Syndrome Following Hematopoietic Stem Cell Transplantation.
Boynton GE; Raoof D; Niziol LM; Hussain M; Mian SI
Cornea; 2015 Jul; 34(7):725-32. PubMed ID: 25850708
[TBL] [Abstract][Full Text] [Related]
19. Comparison of visual and refractive outcomes following femtosecond laser- assisted lasik with smile in patients with myopia or myopic astigmatism.
Ganesh S; Gupta R
J Refract Surg; 2014 Sep; 30(9):590-6. PubMed ID: 25250415
[TBL] [Abstract][Full Text] [Related]
20. Moisture chamber goggles for the treatment of postoperative dry eye in patients receiving SMILE and FS-LASIK surgery.
Huang T; Wang Y; Zhu Z; Wu Q; Chen D; Li Y
BMC Ophthalmol; 2023 Dec; 23(1):501. PubMed ID: 38066467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
